Jim Cramer highlighted Incyte as a top S&P 500 winner on June 30, 2025.

The entities involved

• Incyte →

  American pharmaceutical company

  • Incyte, a biotech company based in Wilmington, outperformed the biotech ETF.Thu 13:11
  • Incyte is presenting data at the European Academy of Dermatology and Venereology (EADV) conference held in Vienna.Tue 13:24
• Jim Cramer →

  American stockbroker, television personality, author

  • Jim Cramer offers market commentary on Target Corporation's performance.Sun 22:26
  • Mastercard is noted to be benefiting from the economic tailwinds of Trump-era tariffs and onshoring policies.Sun 15:21

Related events

• Jim Cramer highlighted Freeport-McMoRan (FCX) as a top S&P 500 winner on June 30, 2025.Jun 8
• Cramer showed bullish sentiment toward a stock on July 4, 2025.Jun 8
• Jim Cramer discussed Snowflake Inc.'s stock performance on September 5, 2025.Jun 7
• Jim Cramer stated that he views Meta as a fantastic company.Jun 8
• Jim Cramer discussed CrowdStrike's potential as an investment on July 11, 2025.Jun 8